| AN2828 | |
|---|---|
| Uniprot | Q5B9F2 |
| Length | 737 |
Bioinformatic-based prediction
| Signal peptide | |
|---|---|
| SignalP | Yes |
| Phobius | Yes |
| Uniprot annotation with experimental evidence | NA |
| Transmembrane domain | |
| TMHMM | No |
| Phobius | No |
| Uniprot annotation with experimental evidence | NA |
| GPI anchor | |
| bigPI | No |
| PredGPI | No |
| Uniprot annotation with experimental evidence | NA |
| Subcellular localization | |
| WolF Psort1 | E |
| Protcomp1 | R |
| TargetP1 | S |
| Uniprot annotation with experimental evidence | NA |
1Following letter codes were used for different subcellular localization predictions from WoLF PSORT, Protcomp and TargetP:
P - Plasma membrane, E - Extracellular, S - Secretory pathway, M - Mitochondrial, ER - Endoplasmic reticulum, C- Cytoplasmic/Cytosol, L- Lysosomal,
G - Golgi apparatus, N - Nuclear, V - Vacuolar, R - Peroxisomal, CN - Cytosol and Nucleus, CK - Cytoskeleton, CM - Cytosol and Mitochondria, _ - Other
| Endoplasmic reticulum (ER) retention signal | |
|---|---|
| PS SCAN | No |
| Abundance of Antigenic Regions (AAR) | |
|---|---|
| Kolaskar & Tongaonkar | 23.031 |
| BepiPred | 67 |
| Annotation | |
|---|---|
| Gene Ontology (GO) | GO:0005975, GO:0004553 carbohydrate metabolic process (BP), hydrolase activity, hydrolyzing O-glycosyl compounds (MF) |
| CAZy | GH3 |
| Pfam | PF01915.21, PF00933.20, PF14310.5 Glycosyl hydrolase family 3 C-terminal domain, Glycosyl hydrolase family 3 N terminal domain, Fibronectin type III-like domain |
| TIGRFAM | NA NA |
| SFLD | NA NA |
| SMARTS | NA NA |
| CDD | NA NA |
| Prosite Profiles | NA NA |
| Prosite Patterns | NA NA |
| SUPERFAMILY | SSF51445,SSF52279 , |
| PRINTS | PR00133,PR00133,PR00133,PR00133,PR00133 Glycosyl hydrolase family 3 signature,Glycosyl hydrolase family 3 signature,Glycosyl hydrolase family 3 signature,Glycosyl hydrolase family 3 signature,Glycosyl hydrolase family 3 signature |
| COILS | NA NA |
| MobiDB lite | NA NA |
Similar drug target from DrugBank
| Drug target ID | Blastp e-value | Potential drugs |
|---|---|---|
| P40406 | 2.16E-10 | DB08357 |